Abstract
Currently, atherosclerosis accounts for the majority of cardiovascular morbidity and mortality worldwide, and predicting the stability of atherosclerotic plaque is the main method to prevent atherosclerotic death. This study aims to establish a dual-label time-resolved fluorescence immunoassay (TRFIA) of matrix metalloprotein-9 (MMP-9) and lipoprotein-associated phospholipaseA2 (Lp-PLA2) to predict atherosclerotic plaque stability. A dual-label TRFIA was introduced for the simultaneous quantification of MMP-9 and Lp-PLA2 using fluorescent lanthanide (Eu3+ and Sm3+) chelates. The performance (sensitivity, specificity, accuracy, precision and reference intervals in different subjects) of this TRFIA was evaluated and compared with commercial kit. The sensitivity of the TRFIA for MMP-9 was 0.85 ng/mL and for Lp-PLA2 was 0.68 ng/mL with high affinity and specificity. The average recoveries were 94.58% to 109.82%, and 104.32% to 109.26%, respectively. All intra- and inter-assay CVs ranged from 3.10% to 5.46%. For the normal subjects, the cutoff value was 160.70 ng/mL for MMP-9 and 183.73 ng/mL for LP-PLA2; for the subjects with stable plaque, the cutoff value was 181.98~309.22 ng/mL for MMP-9 and 194.73~337.89 ng/mL for LP-PLA2; for the subjects with unstable plaque, the cutoff value was 330.43 ng/mL for MMP-9 and 343.23 ng/mL for LP-PLA2. This TRFIA detection results agreed well with the results of commercial kit (R2=0.9567 and R2=0.9771, respectively) in clinical serum samples. The TRFIA developed has a wide detection range and good sensitivity for the high-throughput simultaneous detection of MMP-9 and Lp-PLA2 in serum, which provides a new method for predicting the stability of atherosclerotic plaque.
Similar content being viewed by others
Data Availability
The data used and/or analysed in the current study are given in the submitted article.
References
Newby AC (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85(1):1–31. https://doi.org/10.1152/physrev.00048.2003
Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25(10):2054–2061. https://doi.org/10.1161/01.ATV.0000178991.71605.18
Silvera SS, Aidi HE, Rudd JH, Mani V, Yang L, Farkouh M, Fuster V, Fayad ZA (2009) Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Atherosclerosis 207(1):139–143. https://doi.org/10.1016/j.atherosclerosis.2009.04.023
Koenig W, Khuseyinova N (2007) Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 27(1):15–26. https://doi.org/10.1161/01.ATV.0000251503.35795.4f
Ramos-Lopes J, Varela R, Rui P et al (2021) Phospholipase A2 and Ischemic Stroke Etiology. The Neurologist 26(2):32–35. https://doi.org/10.1097/NRL.0000000000000329
Silvello D, Narvaes LB, Albuquerque LC, Forgiarini LF, Meurer L, Martinelli NC, Andrades ME, Clausell N, dos Santos KG, Rohde LE (2014) Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability. Biomarkers 19(1):49–55. https://doi.org/10.3109/1354750X.2013.866165
Watanabe N, Ikeda U (2004) Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep 6(2):112–120. https://doi.org/10.1007/s11883-004-0099-1
Reininghaus EZ, Lackner N, Birner A, Bengesser S, Fellendorf FT, Platzer M, Rieger A, Queissner R, Kainzbauer N, Reininghaus B, McIntyre RS, Mangge H, Zelzer S, Fuchs D, Dejonge S, Müller N (2016) Extracellular matrix proteins matrix metallopeptidase 9 (MMP9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder. Bipolar Disord 18(2):155–163. https://doi.org/10.1111/bdi.12380
Saneipour M, Ghatreh-Samani K, Heydarian E, Farrokhi E, Abdian N (2015) Adiponectin inhibits oxidized low density lipoprotein-induced increase in matrix metalloproteinase 9 expression in vascular smooth muscle cells. ARYA Atheroscler 11(3):191–195
Mathapati S, Arumugam SB, Verma RS (2010) High cholesterol diet increases MMP9 and CD40 immunopositivity in early atherosclerotic plaque in rabbits. Acta Histochem 112(6):618–623. https://doi.org/10.1016/j.acthis.2009.05.011
Macphee CH, Nelson J, Zalewski A (2006) Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target. Curr Opin Pharmacol 6(2):154–161. https://doi.org/10.1016/j.coph.2005.11.008
Kolodgie FD, Burke AP, Skorija KS, Ladich E, Kutys R, Makuria AT, Virmani R (2006) Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 26(11):2523–2529. https://doi.org/10.1161/01.ATV.0000244681.72738.bc
Lin G, Chen S, Zhao H et al (2017) A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency. Sci Rep 7(1):7288. https://doi.org/10.1038/s41598-017-07687-7
Itaru S, Hiromichi I, Shigemitsu O et al (2015) Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy? J Radiat Res 56(2):354–359. https://doi.org/10.1093/jrr/rru116
Pirillo A, Catapano AL (2013) Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases. Dis Markers 35(5):413–418. https://doi.org/10.1155/2013/716325
Geng YJ, Phillips JE, Mason RP, Casscells SW (2003) Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and rupture. Biochem Pharmacol 66(8):1485–1492. https://doi.org/10.1016/S0006-2952(03)00502-1
Verma S, Devaraj S, Jialal I (2006) Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 113(17):2135–2150
Liu Y, Liu YH, Bei WJ, Wang K, Cui TT, Li HL, Wu DX, Chen SQ, Tan N, Chen JY (2017) A dual-label time-resolved fluorescence immunoassay for the simultaneous determination of cystatin C and β2-microglobulin in urine. Br J Biomed Sci 74(4):193–197. https://doi.org/10.1080/09674845.2017.1334740
Liu Z, Huang J, Ou RM, Yao MD, She YL, Chen R, Li C, Xu L, Abudureyimu A, Zhang Q, Liu S (2017) A dual-label time-resolved fluorescence immunoassay for the simultaneous determination of ferritin and β2 -microglobulin. J Clin Lab Anal 31(6):e22132. https://doi.org/10.1002/jcla.22132
Le T, Yan P, Liu J, Wei S (2013) Simultaneous detection of sulfamethazine and sulfaquinoxaline using a dual-label time-resolved fluorescence immunoassay. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 30(7):1264–1269. https://doi.org/10.1080/19440049.2013.801084
Zhang Z, Liu JF, Shao B, Jiang GB (2010) Time-resolved fluoroimmunoassay as an advantageous approach for highly efficient determination of sulfonamides in environmental waters. Environ Sci Technol 44(3):1030–5. https://doi.org/10.1021/es903328b
Zhang Z, Liu X, Li Y, Huang R, Wang L, Li L, Chen C, Ou L, Chang X, Qiao Q, Chen M (2017) A dual-label time-resolved fluorescence immunoassay (TRFIA) for screening of Coronary atherosclerosis based on simultaneous detection of Lp-PLA2 and HsCRP. Immunol Lett 182:12–17. https://doi.org/10.1016/j.imlet.2016.12.004
Namiki M, Kawashima S, Yamashita T, Ozaki M, Hirase T, Ishida T, Inoue N, Hirata K, Matsukawa A, Morishita R, Kaneda Y, Yokoyama M (2002) Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol 22(1):115–120. https://doi.org/10.1161/hq0102.102278
Funding
This study was supported by the Science and Technology Plan Development Project of Jilin Province (No. 20200201529JC).
Author information
Authors and Affiliations
Contributions
Hong-yan Ma and Lai-qing Li: Conceptualization, Methodology and Writing- Original draft preparation. Qian Mao, Yan-bin Zhu, Chun-li Cong and Shi-yu Zheng: Serum samples collection. Qi Zhang: Samples screening. Cui-cui Chen: Method optimization. Qian Mao and Yan-bin Zhu: Software and Data analysis.
Corresponding author
Ethics declarations
Ethics Approval
The Institutional Review Board of Beihua University Affiliated Hospital approved this study, and all subjects gave written informed consent.
Consent to Participate
No applicable.
Consent for Publication
No applicable.
Conflicts of Interest
The authors declared that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ma, Hy., Mao, Q., Zhu, Yb. et al. Time-resolved Fluorescence Immunoassay (TRFIA) for the Simultaneous Detection of MMP-9 and Lp-PLA2 in Serum. J Fluoresc 31, 1771–1777 (2021). https://doi.org/10.1007/s10895-021-02811-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10895-021-02811-3